Related Experiment Video
Updated: May 11, 2026

10:36
Rare Event Detection Using Error-corrected DNA and RNA Sequencing
Published on: August 3, 2018
12.1K
A single cell RNAseq benchmark experiment embedding "controlled" cancer heterogeneity
Maddalena Arigoni1, Maria Luisa Ratto1, Federica Riccardo1
1Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
Scientific Data
|February 2, 2024
Summary
Single-cell RNA sequencing (scRNA-seq) aids tumor research by exploring individual cell complexities. This study presents a lung cancer dataset to benchmark algorithms for analyzing cancer heterogeneity using scRNA-seq.
Area of Science:
- Oncology
- Genomics
- Bioinformatics
Background:
- Single-cell RNA sequencing (scRNA-seq) is crucial for tumor research, offering insights into cellular molecular complexities.
- Analyzing scRNA-seq data presents challenges in cell annotation and tumor subpopulation identification, necessitating robust bioinformatics methods.
- Benchmarking datasets are vital for validating these methodologies in cancer research.
Purpose of the Study:
- To present a 10X Genomics scRNA-seq dataset for benchmarking bioinformatics tools.
- To provide a controlled heterogeneous environment for studying lung cancer cell lines.
- To facilitate the development and validation of methods for analyzing cancer heterogeneity.
Main Methods:
- Conducted a 10X Genomics scRNA-seq experiment.
- Utilized lung cancer cell lines characterized by specific driver gene expression (EGFR, ALK, MET, ERBB2, KRAS, BRAF, ROS1).
- Created a heterogeneous cellular environment with partially overlapping functional pathways.
Main Results:
- Generated a comprehensive scRNA-seq dataset from characterized lung cancer cell lines.
- Established a controlled experimental setup for evaluating bioinformatics algorithms.
- The dataset enables the study of cancer heterogeneity at the single-cell level.
Conclusions:
- The presented dataset serves as a valuable resource for the oncology research community.
- It supports the development and validation of advanced scRNA-seq analysis methodologies.
- This work addresses the need for robust tools to decipher complex cancer biology.

